Prometheus Biosciences, Inc.
RXDXDelisted Jun 16, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001718852
Prometheus Biosciences, Inc. was delisted on Jun 16, 2023; its insiders filed their last Form 4 on Jun 16, 2023; 220 institutions reported holding it in 13F filings for Q1 2023, worth $4.35B in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Prometheus Biosciences, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 221
- +78 vs. Q3 2022
- Shares held
- 38.1M
- +5.23M (+15.9%) vs. Q3 2022
- Total value
- $4.19B
- +$2.25B (+116.2%) vs. Q3 2022
- New holders
- 94
- 72 more added
- Sold out
- 16
- 47 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RXDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 2 | $1.98M |
| Q1 2023 | 220 | $4.35B |
| Q4 2022 | 221 | $4.19B |
| Q3 2022 | 144 | $1.94B |
| Q2 2022 | 116 | $869.7M |
| Q1 2022 | 103 | $1.04B |
| Q4 2021 | 74 | $1.01B |
| Q3 2021 | 51 | $573.2M |
| Q2 2021 | 49 | $585.6M |
| Q1 2021 | 41 | $425.7M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Prometheus Biosciences, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Price T Rowe Associates Inc | 455,059 | $50.1M | 0.01% | +359,970+378.6% | Added |
| Franklin Resources Inc | 461,848 | $50.8M | 0.03% | −66,789−12.6% | Reduced |
| Federated Hermes, Inc. | 522,401 | $57.5M | 0.16% | +202,267+63.2% | Added |
| Geode Capital Management, LLC | 646,647 | $71.1M | 0.01% | +110,263+20.6% | Added |
| D. E. Shaw & Co., Inc. | 725,229 | $79.8M | 0.13% | +563,848+349.4% | Added |
| FMR LLC | 754,720 | $83.0M | 0.01% | +337,481+80.9% | Added |
| T. Rowe Price Investment Management, Inc. | 864,539 | $95.1M | 0.07% | +457,288+112.3% | Added |
| CHI Advisors LLC | 923,800 | $101.6M | 27.07% | −677,985−42.3% | Reduced |
| Rock Springs Capital Management LP | 1,031,550 | $113.5M | 2.73% | +386,143+59.8% | Added |
| Eventide Asset Management, LLC | 1,032,938 | $113.6M | 2.24% | −1,636,317−61.3% | Reduced |
| Adage Capital Partners GP, L.L.C. | 1,101,839 | $121.2M | 0.29% | −63,161−5.4% | Reduced |
| Perceptive Advisors LLC | 1,212,694 | $133.4M | 3.84% | −255,818−17.4% | Reduced |
| Point72 Asset Management, L.P. | 1,266,083 | $139.3M | 0.53% | +673,187+113.5% | Added |
| State Street Corp | 1,348,180 | $148.3M | 0.01% | −237,894−15.0% | Reduced |
| Fred Alger Management, LLC | 1,359,256 | $149.5M | 0.81% | +323,091+31.2% | Added |
| 72 Investment Holdings, LLC | 1,848,024 | $203.3M | 93.46% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,856,255 | $204.2M | 0.01% | +294,649+18.9% | Added |
| Boxer Capital, LLC | 1,897,500 | $208.7M | 11.23% | +183,500+10.7% | Added |
| Cormorant Asset Management, LP | 2,090,000 | $229.9M | 15.45% | +110,842+5.6% | Added |
| BlackRock Inc. | 2,807,704 | $308.8M | 0.01% | +673,432+31.6% | Added |
| RTW Investments, LP | 3,354,303 | $369.0M | 7.53% | +164,698+5.2% | Added |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −262,702−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −133,831−100.0% | Sold out |
| Tri Locum Partners LP | 0 | $0 | 0.00% | −123,599−100.0% | Sold out |
| VR Adviser, LLC | 0 | $0 | 0.00% | −121,663−100.0% | Sold out |
| Empowered Funds, LLC | 0 | $0 | 0.00% | −39,890−100.0% | Sold out |
| Putnam Investments LLC | 0 | $0 | 0.00% | −36,713−100.0% | Sold out |
| Calamos Advisors LLC | 0 | $0 | 0.00% | −25,612−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −19,190−100.0% | Sold out |
| Raymond James Financial Services Advisors, Inc. | 0 | $0 | 0.00% | −13,036−100.0% | Sold out |
| Chartwell Investment Partners, LLC | 0 | $0 | 0.00% | −9,408−100.0% | Sold out |
| Winton Group Ltd | 0 | $0 | 0.00% | −7,311−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −4,956−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −4,206−100.0% | Sold out |
| PEAK6 Investments LLC | 0 | $0 | 0.00% | −4,000−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −3,460−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −1,627−100.0% | Sold out |
| Dowling & Yahnke LLC | – | – | – | – | Not filed |